Navigation Links
GlaxoSmithKline Presents Innovative Neuroscience Pipeline
Date:12/13/2007

PHILADELPHIA and LONDON, Dec. 13 /PRNewswire-FirstCall/ -- GlaxoSmithKline (GSK) plc today presented an overview of its neuroscience portfolio and the company's disease area strategy to investors and analysts at a meeting in New York.

Highlights

-- Innovative neuroscience pipeline spans 13 different disease areas

including Alzheimer's disease, depression, schizophrenia, and multiple

sclerosis (MS):

- More than 25 innovative compounds currently in development with 15

new mechanisms of action

-- New "proof of concept" data presented on promising phase II compounds

773812 for schizophrenia and 742457 for Alzheimer's disease:

- Both assets to progress to large-scale phase IIb trials assessing

efficacy and safety compared to leading marketed therapies

-- Phase II program for use of ofatumumab in multiple sclerosis

announced, with trials involving approximately 300 patients starting in

2008:

-- Phase III treatment, 1838262, profiled:

- Filing for restless legs syndrome (RLS) expected in third quarter of

2008

- New phase III program for migraine prophylaxis planned

- New phase II studies in neuropathic pain announced

-- Four CNS products with potential to be launched or approved in 2008:

- Trexima potential "new gold standard" for migraine;

- Lamictal XR new once daily treatment for epilepsy;

- Lunivia, a successful treatment for insomnia in the US, expected to

be launched in Europe;

- Requip XL the first non-ergot once daily dopamine agonist for the

treatment of Parkinson's disease

-- Overall pipeline progress continues:

- 8 approvals, 8 filings and 9 key assets starting phase III trials so

far in 2007

- GSK confirms FDA filing of Promacta, a new oral treatment for short-'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. GlaxoSmithKline Responds to JAMA Articles
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
4. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
5. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
6. GlaxoSmithKline Aids California Fire Relief Efforts
7. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
8. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
9. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
10. Updated GOLD report presents new understandings in diagnosis, treatment and prevention of COPD
11. The Art Of Maternity(TM) at Destination Maternity(R) Presents A Sacred Passage Into Motherhood; the Art of Belly Masking to Belly Casting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... With the arrival of summer, VisitandCare.com today ... and hair transplant procedures, up 80 percent from July ... medical tourism destinations, the company is helping patients take ... achieve the look they have always desired. , ... in the medical tourism industry, VisitandCare.com is comprised of ...
(Date:7/11/2014)... Steven Reinberg HealthDay ... Stress, hostility and depression may increase the risk for stroke, ... seemed to raise the risk of a stroke or ... found that stress apparently raised stroke or TIA risk by ... A TIA is a mini-stroke caused by a temporary blockage ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Fadhits.com, the ... its elegant assortment of lace holiday dresses . ... products are now offered at discounted prices, up to ... website can enjoy this special offer. , Fadhits.com ... and special occasion dresses for the global clients. All ...
(Date:7/11/2014)... San Francisco shows that an "expressive therapy" group ... living with HIV disclose their health status and ... and quality of their relationships., "Medication alone is ... L. Machtinger, MD, director of the Women,s HIV ... patients are on effective antiretroviral therapy but far ...
(Date:7/11/2014)... CA (PRWEB) July 11, 2014 Bedros Keuilian ... expert; a title he’s earned by founding the fast-selling fitness ... on marketing their businesses. He works with successful boot camp ... blog post on the traits of the most successful boot ... share three important qualities. , “I’ve worked with and coached ...
Breaking Medicine News(10 mins):Health News:VisitandCare.com Reports Increase in Cosmetic and Hair Transplant Procedures for Men 2Health News:VisitandCare.com Reports Increase in Cosmetic and Hair Transplant Procedures for Men 3Health News:Stress, Depression May Boost Stroke Risk, Study Finds 2Health News:Stress, Depression May Boost Stroke Risk, Study Finds 3Health News:Elegant Lace Holiday Dresses Released by Fadhits.com 2Health News:'Expressive therapy" intervention assists women living with HIV 2Health News:Fitness Boot Camp Marketing Expert Bedros Keuilian Shares the Top Three Traits of Successful Boot Camp Owners 2Health News:Fitness Boot Camp Marketing Expert Bedros Keuilian Shares the Top Three Traits of Successful Boot Camp Owners 3
... a leader in the field of clinical supply chain management, announced today ... the MHS Board of Directors. www.mhsinc.com , ... Fairfield, Connecticut ... a leader in the field of clinical supply chain management, announced today ...
... A team of Slimband employees successfully competed in the 19th Annual Canada Life ... , ... ON (PRWEB) April 22, 2009-- A team of Slimband employees successfully ... took place on April 16th. The CN Tower Climb is a demanding ...
... Committee,s (SASC) report on detainee abuse, Physicians for Human Rights (PHR) ... for the Central Intelligence Agency (CIA) and Department of Defense (DoD), ... , ... (Vocus) April 21, 2009 -- In the wake ...
... Only two percent of hospitals nationwide receive Magnet ... Center (ANCC) has announced that Baylor University ... earned re-designation as a Magnet hospital, effective immediately. ... been designated at a Magnet hospital, and merely ...
... to Save Millions of Plastic Bags from LandfillsITASCA, Ill., ... drug retailer, is partnering with WFLD FOX Chicago this ... Reuse" challenge, an initiative aimed at increasing consumer use ... plastic bags from ending up in area landfills. The ...
... 21 Carl Icahn announced today that he had sent the following letter to Joseph C. Cook, ... AMLN ) concerning recent discussions between Mr. Icahn and Messrs. Cook and Wilson , , ... ... April 21, 2009, Joseph Cook, Jr., Chairman of ...
Cached Medicine News:Health News:Daniel C. Lubin Joins Management Health Solutions, Inc. Board of Directors 2Health News:Slimband™ Team Competes in CN Tower Climb and Helps Fight Against Global Warming 2Health News:PHR: After Senate Report, Psychologists Who Tortured Must Be Held to Account 2Health News:PHR: After Senate Report, Psychologists Who Tortured Must Be Held to Account 3Health News:PHR: After Senate Report, Psychologists Who Tortured Must Be Held to Account 4Health News:Baylor Dallas Nationally Recognized for Nursing Excellence 2Health News:JEWEL-OSCO & FOX Chicago Launch 'Choose to Reuse' Bag Program 2Health News:JEWEL-OSCO & FOX Chicago Launch 'Choose to Reuse' Bag Program 3Health News:Icahn Responds to Cook and Wilson 2Health News:Icahn Responds to Cook and Wilson 3Health News:Icahn Responds to Cook and Wilson 4
(Date:1/15/2014)... DUBLIN , January 15, 2014 Shire plc ... waived the Office of Fair Trading (OFT) approval condition to the ... Incorporated (NASDAQ: VPHM).   As a result of the ... Shire expects to complete the tender offer on January 24, 2014 ...
(Date:1/15/2014)... NEW YORK , January 15, 2014 ... BreedIT Ltd., the exclusive worldwide distributor of highly sophisticated ... that on January 7, 2014, the Company,s board of ... Ben-Zion Weiner as its new member of the ...
(Date:1/15/2014)... PALM BEACH GARDENS, Fla. , Jan. 15, 2014  In an ... C. difficile and TB in ambulances and other transport vehicles, an ... being used by rescue personnel for the first time. ... coming in contact with these deadly pathogens, West Palm ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Superbugs No Longer Ride In Rescue Vehicles 2
... , , SAN DIEGO, Aug. 27 ... Company has begun a clinical trial intended to secure U.S. regulatory approval ... determine the need for a repeat prostate biopsy. , ... studies and our European commercial experience, we believe that our PROGENSA PCA3 ...
... , , , ... an 82-year old New Orleans resident with severe aortic stenosis successfully had ... as angioplasty, a far cry from the traditional open heart procedure. Patients ... now have a potential new research option available regionally only through The ...
Cached Medicine Technology:Gen-Probe Begins U.S. Clinical Study of PROGENSA(R) PCA3 Assay, New Molecular Test to Help Assess Prostate Cancer Risk 2Gen-Probe Begins U.S. Clinical Study of PROGENSA(R) PCA3 Assay, New Molecular Test to Help Assess Prostate Cancer Risk 3Gen-Probe Begins U.S. Clinical Study of PROGENSA(R) PCA3 Assay, New Molecular Test to Help Assess Prostate Cancer Risk 4Ochsner Replaces Heart Valve Without Open Heart Surgery 2
Easy-to-use system for displaced femoral neck fractures in the low demand patient....
The APR Hip System offers a complete line of stems to precisely match patients' anatomic needs and address surgeon preferences....
Dual offset femoral stems, hip stems that provide unique and competitive features....
The P.S.L. stem is manufactured from cobalt chrome and is available with or without porous coating to give the surgeon the option of utilizing either the cementless of cemented technique at his or he...
Medicine Products: